Xu et al. [13] identified a crucial tumor suppressive role of miR-424 in the progression of cervical cancer at least partly via upregulating the expression of Chk1 and p-Chk1, suggesting that miR-424 may be a candidate of prognostic predictor or an anticancer therapeutic target for cervical cancer patients. Here, CHEK1 is linked to cervical cancer.